2 secret small-cap growth stocks I think you need to know about

These market minnows have been quietly making their owners a lot of money. Paul Summers take a closer look.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

As someone with a relatively high risk appetite when it comes to investing, I’m always on the lookout for small, fast-growing companies that could deliver significant capital gains over time. All the better if these businesses also happen to be flying under most market participants’ radars.

While the past is certainly no guide to the likelihood of more success in the future, here are two that have caught my eye recently.

Star performer

I’d bet that most retail investors haven’t heard of £180m cap, AIM-listed Bioventix (LSE: BVXP). Assuming the company is able to continue performing as it has over the last few years, however, this could be all set to change. 

For background, it develops and supplies antibodies that are then used in blood testing machines in laboratories and hospitals. These tests are employed in fields such as fertility, cancer and heart disease.

Although the company has been fairly quiet over the last few months, October’s results for the full year to the end of June were hugely encouraging. Revenue jumped 21% to £8.8m with pre-tax profits climbing 19% to £6.9m.

Those who like to see strong balance sheets may also like to know that Bioventix was debt-free and had £7m in cash when these numbers were announced.

While dividends aren’t of much interest to a lot of growth investors, it’s worth mentioning that the small-cap returned 61p per share to holders last year — a near 20% increase on 2016/17. There was also a special dividend of 55p per share.

Perhaps unsurprisingly, Bioventix’s share price has rocketed almost 75% over the last year. Had you bought the shares when the company first listed back in 2014, you’d have multiplied your money well over five times

The only negative with this — at least for prospective buyers — is that the stock now trades on a seriously expensive valuation of 32 times forecast earnings. 

Would I buy the shares now? Probably not. The general sell-off in equities towards the end of 2018 was a reminder of the dangers of paying too much for any company, regardless of its quality. With Brexit coming next month, the possibility of stock markets becoming choppy once again is real.

That said, if markets do dip, I’m certainly not ruling out buying a slice of Bioventix at a better price.

High confidence

Another company that’s been in fine form recently is D4t4 Solutions (LSE: D4T4). Ignore the questionable name for a second. Over the last year, the data solutions provider’s valuation has increased 55%.

November’s half-year results showed evidence of strong revenue growth. At just under £14m, this was almost 200% higher than over the same period in the previous year. The company also reported an adjusted pre-tax profit of £3.35m compared to a £380,000 loss in 2017.  

Commenting on the company’s outlook, CEO Peter Kear reflected that the business had “a strong pipeline of opportunities” and that D4t4 was looking forward to the rest of the year “with a high degree of confidence“. 

Interestingly, unlike Bioventix, the stock isn’t all that pricey for a business experiencing such growth — a little under 19 times earnings for the current year (ending 31 March).

Dividends are fairly negligible at this point (a yield of 1.2%) but these are rising fast.  The interim dividend was raised 12% to 0.7p per share. There’s also no debt and a solid cash position (just over £12m at the half-year point).

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be considered so you should consider taking independent financial advice.

Paul Summers has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Content white businesswoman being congratulated by colleagues at her retirement party
Investing Articles

How I’d invest £5,000 in FTSE 100 shares to aim for a million

The FTSE 100 is home to many potential gems. Our writer considers if he can reach millionaire status by uncovering…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

How I’m aiming to become a Stocks and Shares ISA millionaire!

The Stocks and Shares ISA is an excellent vehicle for investments. In fact, many investors have become ISA millionaires. Here's…

Read more »

Mixed-race female couple enjoying themselves on a walk
Investing Articles

The Scottish Mortgage share price is on the up! Here’s why I’d buy

After a poor first half of the year, the Scottish Mortgage share price is beginning to rise. Here, this Fool…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing Articles

Should I be grabbing cheap Lloyds shares?

Lloyds shares have underperformed in recent years. Here, this Fool explains why he's still considering the stock for his portfolio.

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

How I’m using UK dividend shares to try and turn £20,000 into £100,000

Our writer has ambitious investment goals -- and patience. Here he explains how he's buying UK dividend shares to try…

Read more »

Middle-aged lady in wheelchair writing on whiteboard
Investing Articles

I’m taking a defensive stance by investing in the FTSE ahead of the recession

The FTSE has outperformed several indices in 2022, including the S&P 500. Jacob Ambrose Willson believes it can be used…

Read more »

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop
Investing Articles

Should I buy BP shares today?

BP is generating huge profits right now. Here, Edward Sheldon looks at whether he should buy shares in the oil…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Should I buy Rolls-Royce shares after the latest results?

Jon Smith runs over the key points from half-year results for Rolls-Royce shares to see if any green shoots are…

Read more »